Bioequivalence
Bioequivalence studies play a critical role in bringing safe, effective, and affordable therapies to patients. CenExel partners with sponsors to conduct high-quality bioequivalence research that demonstrates therapeutic equivalence between generic and reference products while meeting regulatory requirements and timelines.
Studies Conducted
0
+
Trial Participants
0
+
Active Centers
0
Overview
Comprehensive Bioequivalence Research Solutions
Our bioequivalence research programs support pharmaceutical and biotechnology sponsors throughout the development and approval process for generic and reformulated products.
With extensive experience in pharmacokinetic (PK), pharmacodynamic (PD), fasting, fed-state, and comparative bioavailability studies, our teams deliver accurate data collection, regulatory compliance, and efficient study execution.
From protocol development through final reporting, CenExel provides the scientific expertise and operational excellence needed to accelerate product development and regulatory submissions.
Conditions Covered
Bioequivalence Studies We Conduct
Our research sites support a broad range of bioequivalence and comparative pharmacology studies.
Oral Solid Dosage Forms
Modified Release Products
Immediate Release Formulations
Generic Drug Development
Comparative Bioavailability Studies
Fasting Studies
Fed-State Studies
Pharmacokinetic Studies
Pharmacodynamic Assessments
Drug-Drug Interaction Studies
Our Approach
Why Sponsors Choose CenExel for Bioequivalence
Our bioequivalence expertise extends beyond study execution—we provide strategic scientific guidance and operational efficiency throughout every phase of development.
01
Regulatory Expertise
Deep understanding of FDA and global bioequivalence requirements.
02
Specialized PK Capabilities
Extensive experience in pharmacokinetic sampling, analysis, and reporting.
03
Rapid Recruitment
Access to diverse healthy volunteer populations for timely enrollment.
04
High-Quality Data
Consistent study execution with robust quality assurance processes.
Phase Coverage
Supported Trial Phases
CenExel supports a wide range of bioequivalence and comparative bioavailability studies, including pilot studies, pivotal registration studies, food-effect assessments, and specialized pharmacokinetic evaluations.
Active phases
Phase I
Phase II
Let’s Advance Your Next Study
Looking for an experienced clinical research partner with the expertise, capabilities, and reach to move your study forward? Connect with CenExel to discuss your needs and explore how our network can support your clinical development goals.
Explore Our Network
Discover CenExel’s Centers of Excellence and find the locations, therapeutic expertise, and capabilities that align with your clinical development needs.